未找到相关数据
Phase II results of GANNET53: A European multicenter phase I/randomized II trial of the Hsp90 inhibitor Ganetespib (G) combined with weekly Paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.
被引：5
作者：
Concin, Nicole
Braicu, Ioana
Combe, Pierre
Ray-Coquard, Isabelle Laure
Joly, Florence
Harter, Philipp
机构：
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.5567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5567
引用
收藏
页数：2
相关论文